Skip to content
Open access

Sex differences in lipid management among high-risk patients without prior myocardial infarction or stroke: results from the VESALIUS-REAL global study

Oct 2026 · European Heart Journal · Vol 47 · 0 citations

TL;DR

Women at high cardiovascular risk consistently experienced less intensive lipid management and LDL-C goal achievement compared with men, highlighting similar sex differences in risk factors and lipid management across regions and underscore the need for targeted strategies to improve implementation of guideline-directed LLT in women at high cardiovascular risk.

Abstract

Effective lipid-lowering therapy (LLT) reduces the risk of cardiovascular outcomes in patients at high cardiovascular risk, as well as in those without a history of myocardial infarction (MI) or stroke. The VESALIUS-CV trial demonstrated the benefit of intensive low-density lipoprotein cholesterol (LDL-C) lowering in such patients, reducing the risk of major cardiovascular events.1 However, real-world lipid management in this population remains poorly characterised, and evidence suggests persistent sex disparities, with women less likely to receive intensive LLT or achieve guideline-recommended LDL-C levels.2,3 To examine lipid management patterns and LDL-C goal achievement in women and men at high cardiovascular risk without prior MI or stroke in 11 databases from North America, Europe, and Asia-Pacific. Patients aged ≥ 50 years with either documented coronary artery disease (CAD), atherosclerotic cerebrovascular disease (CeVD), peripheral artery disease (PAD), or high-risk diabetes mellitus (DM; defined as DM with microvascular complications or chronic insulin use), plus additional cardiovascular risk factors and elevated lipid levels, but no history of MI or stroke, were selected from de-identified claims or electronic medical records (2017–2022).4 Elevated lipids were defined as ≥ 1 measurement of either LDL-C ≥ 2.3 mmol/L, non–high-density lipoprotein cholesterol ≥ 3.1 mmol/L, or apolipoprotein B ≥ 0.8 g/L. The earliest date when all criteria were met was defined as the index. This analysis summarises LLT use, LLT intensification, and LDL-C goal achievement based on local guidelines by sex. A total of 576,372 women (70% aged ≥ 65 years) and 550,384 men (63% aged ≥ 65 years) were included (Table). Women compared with men had a lower prevalence of CAD (38% vs 42%) and high-risk DM (30% vs 33%), but a higher prevalence of atherosclerotic CeVD (26% vs 22%) and PAD (13% vs 11%). At index, LLT use was similar in women and men (40% each); however, the use of combination therapy as well as LLT intensification within 1 year was slightly lower in women than men (5% vs 7% and 25% vs 29%, respectively). Among patients not on LLT at index, a smaller proportion of women initiated LLT within 1 year compared with men (8% vs 11%). LDL-C testing within 1 year of follow-up was less frequent in women than in men (50% vs 54%). Achievement of guideline-recommended LDL-C levels was also lower in women (17%) vs men (24%), with differences consistent across countries/regions (Figure). In this global real-world study, women at high cardiovascular risk consistently experienced less intensive lipid management and LDL-C goal achievement compared with men. These findings highlight similar sex differences in risk factors and lipid management across regions and underscore the need for targeted strategies to improve implementation of guideline-directed LLT in women at high cardiovascular risk.

Read PDF

Similar papers

Open access Oct 2026

Lipid management in patients with coronary artery disease at risk of a first major atherosclerotic cardiovascular event: findings from the VESALIUS-REAL global study

In this large, global, real-world study, most patients with CAD at risk of a first MACE were undertreated with LLT and did not achieve recommended LDL-C levels, highlighting substantial gaps between guideline recommendations and real-world practice.

Q. Chan, J. Cegla, J. Cornel et al. · 0 citations
Nov 2026

Abstract 6765: Lipid Management Patterns and Low-Density Lipoprotein Cholesterol Goal Attainment Among Patients with High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke in the US Stratified by Race/Ethnicity

Background: Prior studies demonstrate persistent race and ethnic disparities in lipid-lowering therapy (LLT) utilization among patients with prior ischemic events. These disparities may be more pronounced in a high cardiovascular (CV) risk population without prior myocardial infarction (MI) or stroke where patients...

S. Sakhuja, Q. Chan, Corinne Brooks et al. · 0 citations
Review Oct 2026

[LDL-c and residual cardiovascular risk in patients with coronary artery disease].

Although the expanding therapeutic armamentarium allows for increased substantial LDL-c reductions, this has not translated into a corresponding improvement in target attainment and the underlying reasons are complex and multifactorial.

Thomas de Saint Nicolas, Hubert Dromas, Gilles Lemesle · 0 citations
Open access Oct 2026

Sex-difference in cardiovascular outcomes following achieved LDL-C Levels <1.0 mmol/L in patients with coronary artery disease

Women with cardiovascular disease still continue to present substantially higher mortality than men, which highlights the need for appropriate anti-atherosclerotic management. Current ESC/EAS guidelines advocate achieving stricter LDL-C goals (<1.0 and 1.4 mmol/L) for the secondary prevention of ASCVD in very hig...

F. Matsuyama, Y. Katatoka, S. Kitahara et al. · 0 citations
Oct 2026

Lipid risk profile in ACS in young women: contribution of Lp(a) measurement: ancillary analysis of the WAMIF study

Young women presenting with acute coronary syndrome (ACS) represent a distinct clinical phenotype with heterogeneous mechanisms: premature atherosclerosis and non-obstructive coronary disease. In the WAMIF study (Women with Acute Myocardial Infarction), a French national multicenter cohort of women under 50 years...

S. Manzo-Silberman, A. Bellemain-Appaix, R. Khani-Bittar et al. · 0 citations
Nov 2026

Abstract 6058: Absolute versus Relative Low-Density Lipoprotein Cholesterol Lowering and Long-Term Cardiovascular Outcomes in Patients with Diabetes After Acute Myocardial Infarction

Background: Current guidelines recommend that very-high-risk patients with diabetes after acute myocardial infarction (AMI) achieve both an absolute low-density lipoprotein cholesterol (LDL-C) goal of <55 mg/dL and a reduction of ≥50% from baseline. However, in routine practice, many patients fail to achieve both ta...

J. Lee, Yoonsun Won, A. Jang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.